1. Home
  2. CZFS vs GLUE Comparison

CZFS vs GLUE Comparison

Compare CZFS & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CZFS
  • GLUE
  • Stock Information
  • Founded
  • CZFS 1984
  • GLUE 2019
  • Country
  • CZFS United States
  • GLUE United States
  • Employees
  • CZFS N/A
  • GLUE N/A
  • Industry
  • CZFS Major Banks
  • GLUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CZFS Finance
  • GLUE Health Care
  • Exchange
  • CZFS Nasdaq
  • GLUE Nasdaq
  • Market Cap
  • CZFS 275.0M
  • GLUE 308.8M
  • IPO Year
  • CZFS N/A
  • GLUE 2021
  • Fundamental
  • Price
  • CZFS $54.77
  • GLUE $11.06
  • Analyst Decision
  • CZFS
  • GLUE Buy
  • Analyst Count
  • CZFS 0
  • GLUE 2
  • Target Price
  • CZFS N/A
  • GLUE $13.50
  • AVG Volume (30 Days)
  • CZFS 9.3K
  • GLUE 1.2M
  • Earning Date
  • CZFS 10-30-2025
  • GLUE 11-06-2025
  • Dividend Yield
  • CZFS 3.63%
  • GLUE N/A
  • EPS Growth
  • CZFS 15.37
  • GLUE N/A
  • EPS
  • CZFS 6.58
  • GLUE 0.29
  • Revenue
  • CZFS $104,184,000.00
  • GLUE $177,986,000.00
  • Revenue This Year
  • CZFS N/A
  • GLUE $77.63
  • Revenue Next Year
  • CZFS $5.45
  • GLUE N/A
  • P/E Ratio
  • CZFS $8.29
  • GLUE $37.80
  • Revenue Growth
  • CZFS 6.11
  • GLUE 2990.57
  • 52 Week Low
  • CZFS $49.99
  • GLUE $3.50
  • 52 Week High
  • CZFS $75.40
  • GLUE $12.40
  • Technical
  • Relative Strength Index (RSI)
  • CZFS 38.03
  • GLUE 84.06
  • Support Level
  • CZFS $52.63
  • GLUE $7.24
  • Resistance Level
  • CZFS $56.12
  • GLUE $7.87
  • Average True Range (ATR)
  • CZFS 1.80
  • GLUE 0.57
  • MACD
  • CZFS -0.54
  • GLUE 0.33
  • Stochastic Oscillator
  • CZFS 20.93
  • GLUE 90.61

About CZFS Citizens Financial Services Inc.

Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Share on Social Networks: